For the 12 months ended May 31, the product had U.S. sales of $6.7 billion.
Apotex has launched rosuvastatin calcium tablets, the generic equivalent of Crestor by AstraZeneca.
Teva Pharmaceuticals has added Sumatriptan Injection, USP (autoinjector) to its line of generic products.
Sephora is re-launching its private label collection and driving mobile sales with a series of new digital features on its websites and apps that help shoppers whittle through thousands of makeup and beauty tools to find what they're looking for. (Adweek)
Seventeen years after its founding, beauty retailer Bluemercury has opened its 100th store, and this time the retailer has gone bigger.
Markwins Beauty Brands has launched a restructuring of its corporate leadership team just several weeks after the company named a new COO.
Mondelez International has appointed the former executive chairman of PPG Industries as a new member of Mondelez's board.
Two new surveys conducted by the American Association of Clinical Endocrinologists reveal surprising and new information about adults living with type 2 diabetes.
Teva announced that its Octreotide Acetate Injection, 50 mcg/mL, is back in stock and ready to order.
Promius Pharma LLC, a subsidiary of Dr. Reddy's Laboratories, has unveiled a new visual identity and corporate brand centered on the "Power of Humans Being."